Table 4.

Outcomes of patients with SPTC, FPTC-2 and FPTC3 at the time of first follow-up and at the end of follow-up

Parameters	SPTC	FPTC-2	FPTC−3	p
Response to initial therapy, n (%)	n = 630	n = 69	n = 17	0.15
Excellent response	450 (71.4%)	39 (56.5%)	13 (76.5%)
Indeterminate/biochemical incomplete response/structural incomplete response	180 (28.6%)	30 (43.5%)	4 (23.5%)
Clinical outcomes at the end of follow-up, n (%)	n = 626	n = 65	n = 17	0.22
Excellent response	528 (84.3%)	52 (80.0%)	13 (76.5%)
Indeterminate/biochemical incomplete response/structural incomplete response	98 (15.7%)	13 (20.0%)	4 (23.5%)